Skip to content
AwardedPOLGoods

Sukcesywna dostawa leku Agalsidasum Alpha oraz Agalsidasum Beta w ramach programu lekowego - leczenie choroby Fabryego.

Published
Published 10 December 2024
Deadline
Closed 15 January 2025

Overview

Szczegółowy opis przedmiotu zamówienia stanowią załączniki nr 5 do SWZ.

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Open
SME suitable
Yes
Published
10 December 2024
Deadline
Closed
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
PLN 1,866,285
Award date
30 January 2025
Winners
  • Sanofi Sp. z o.o.
  • Takeda Pharma Sp. z o.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    3 February 2025

  2. Contract Notice

    10 December 2024

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Sukcesywna dostawa leku Agalsidasum Alpha oraz Agalsidasum Beta w ramach programu lekowego - leczenie choroby Fabryego. — won by Sanofi Sp. z o.o. +1 — Skim